All Stories

  1. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway
  2. Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China
  3. LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients
  4. Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1–Induced OCT4/Nanog Pathway
  5. [18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models
  6. A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?
  7. Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage
  8. The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A comprehensive analysis
  9. Differentially expressed immune response genes in COVID-19 patients based on disease severity
  10. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation
  11. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase
  12. Virus detection using nanoparticles and deep neural network–enabled smartphone system
  13. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis
  14. COVID-19 induced liver function abnormality associates with age
  15. Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
  16. 2′, 5′-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway
  17. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway
  18. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha–Inducible Protein 6
  19. Tyrosine Kinase SYK is a Potential Therapeutic Target for Liver Fibrosis
  20. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway
  21. Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization
  22. HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus
  23. IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway
  24. Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types
  25. HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response
  26. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
  27. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing
  28. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway
  29. TRAIL Enhances Apoptosis of Human Hepatocellular Carcinoma Cells Sensitized by Hepatitis C Virus Infection: Therapeutic Implications
  30. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus
  31. The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling
  32. A Genetic Screen Identifies Interferon-α Effector Genes Required to Suppress Hepatitis C Virus Replication
  33. Inhibition of HCV by the serpin antithrombin III
  34. ARF1 and GBF1 Generate a PI4P-Enriched Environment Supportive of Hepatitis C Virus Replication
  35. A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus
  36. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism
  37. IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway
  38. HIV infection increases HCV-induced hepatocyte apoptosis
  39. HIV and HCV Cooperatively Promote Hepatic Fibrogenesis via Induction of Reactive Oxygen Species and NFκB
  40. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy
  41. Hepatitis C Virus Regulates Transforming Growth Factor β1 Production Through the Generation of Reactive Oxygen Species in a Nuclear Factor κB–Dependent Manner
  42. Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C Trial
  43. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection
  44. HIV Increases HCV Replication in a TGF-β1–Dependent Manner
  45. Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study
  46. Viral Factors Associated with Cytokine Expression During HCV/HIV Co-Infection
  47. A Cell-Based, High-Throughput Screen for Small Molecule Regulators of Hepatitis C Virus Replication
  48. Hepatitis C Virus Core Protein Blocks Interferon Signaling by Interaction with the STAT1 SH2 Domain
  49. GB Virus C (GBV‐C) Infection in Hepatitis C Virus (HCV)/HIV–Coinfected Patients Receiving HCV Treatment: Importance of the GBV‐C Genotype
  50. Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication
  51. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1
  52. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis